Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Gebauer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Personalized Medicine|May 12, 2018
Status and perspective of lab-on-a-chip systems for common diseases: a systematic review from 2003 to 2013Alexander Gebauer, Silke Schmidt, Wolfgang Hoffmann
Personalized Medicine|May 12, 2018
Diagnostic lab-on-a-chip systems at the doctor's office: a survey amongst German physicians in routine medical careAlexander Gebauer, Holger Muehlan, Wolfgang Hoffmann
International Journal of Audiology|February 21, 2012
Validation of the THI-12 questionnaire for international use in assessing tinnitus: a multi-centre, prospective, observational studyUlli S Bankstahl, Eric P Elkin, Alexander Gebauer, et al.
International Journal of Molecular Sciences|May 28, 2022
The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer's DiseaseHermann Russ, Michele Mazzanti, Chris Parsons, et al.
Thrombosis and Haemostasis|April 21, 2005
Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, with tirofiban in healthy volunteersMarkus Hinder, Anne Paccaly, Annke Frick, et al.
International Journal of Audiology|July 15, 2011
Assessment of tinnitus-related impairments and disabilities using the German THI-12: sensitivity and stability of the scale over timeRoman Görtelmeyer, Jürgen Schmidt, Markus Suckfüll, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Direct and rapid inhibition of factor Xa by otamixaban: a pharmacokinetic and pharmacodynamic investigation in patients with coronary artery diseaseMarkus Hinder, Annke Frick, Pierre Jordaan, et al.
Personalized Medicine|May 17, 2018
Opportunities and risks of diagnostic lab-on-a-chip systems in healthcare from a health system stakeholder's perspectiveWolfgang Hoffmann, Pinar Kuecuekbalaban, Maika Schumann, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 17, 2019
[Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules]Alexander Gebauer, Hagen Barlag, Simone Wesselmann, et al.
Oncology Research and Treatment|July 30, 2018
Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der PraxisCarsten Bokemeyer, Reinhard Busse, Jutta Engel, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 12, 2018
Status and perspective of lab-on-a-chip systems for common diseases: a systematic review from 2003 to 2013Alexander Gebauer, Silke Schmidt, Wolfgang Hoffmann
Personalized Medicine|May 12, 2018
Diagnostic lab-on-a-chip systems at the doctor's office: a survey amongst German physicians in routine medical careAlexander Gebauer, Holger Muehlan, Wolfgang Hoffmann
International Journal of Audiology|February 21, 2012
Validation of the THI-12 questionnaire for international use in assessing tinnitus: a multi-centre, prospective, observational studyUlli S Bankstahl, Eric P Elkin, Alexander Gebauer, et al.
International Journal of Molecular Sciences|May 28, 2022
The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer's DiseaseHermann Russ, Michele Mazzanti, Chris Parsons, et al.
Thrombosis and Haemostasis|April 21, 2005
Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, with tirofiban in healthy volunteersMarkus Hinder, Anne Paccaly, Annke Frick, et al.
International Journal of Audiology|July 15, 2011
Assessment of tinnitus-related impairments and disabilities using the German THI-12: sensitivity and stability of the scale over timeRoman Görtelmeyer, Jürgen Schmidt, Markus Suckfüll, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Direct and rapid inhibition of factor Xa by otamixaban: a pharmacokinetic and pharmacodynamic investigation in patients with coronary artery diseaseMarkus Hinder, Annke Frick, Pierre Jordaan, et al.
Personalized Medicine|May 17, 2018
Opportunities and risks of diagnostic lab-on-a-chip systems in healthcare from a health system stakeholder's perspectiveWolfgang Hoffmann, Pinar Kuecuekbalaban, Maika Schumann, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 17, 2019
[Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules]Alexander Gebauer, Hagen Barlag, Simone Wesselmann, et al.
Oncology Research and Treatment|July 30, 2018
Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der PraxisCarsten Bokemeyer, Reinhard Busse, Jutta Engel, et al.
Pageof 3